4- and 5-Aryl-l-naphthaleneacetic acids as antiinflammatory agents.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004890:Erythema / Q000188:drug therapy / Q000209:etiology; D006168:Guinea Pigs; D009280:Naphthaleneacetic Acids / Q000138:chemical synthesis* / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D014466:Ultraviolet Rays / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D009280:Naphthaleneacetic Acids; D010653:Phenylbutazone